Antibacterial and antitumor activity of Bogorol B-JX isolated from Brevibacillus laterosporus JX-5.

about

Antibacterial and antitumor activity of Bogorol B-JX isolated from Brevibacillus laterosporus JX-5.

Item

http://www.wikidata.org/entity/Q46305244

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@en

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@nl

type

Item

label

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@en

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@nl

prefLabel

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@en

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@nl

P1476

Antibacterial and antitumor ac ...... evibacillus laterosporus JX-5.

@en

P2093

Chao Ji

http://www.w3.org/2001/XMLSchema#string

Hongxia Jiang

http://www.w3.org/2001/XMLSchema#string

Junkang Sui

http://www.w3.org/2001/XMLSchema#string

Rongbo Sa

http://www.w3.org/2001/XMLSchema#string

Tai L Guo

http://www.w3.org/2001/XMLSchema#string

Xiaohui Wang

http://www.w3.org/2001/XMLSchema#string

Xunli Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Determination of minimum inhibitory concentrations

Barrel-stave model or toroidal model? A case study on melittin pores.

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

Antimicrobial cyclic decapeptides with anticancer activity.

Effects of the mitogen concanavalin A on pathways of thymocyte energy metabolism.

The role of cationic antimicrobial peptides in innate host defences.

The expanding scope of antimicrobial peptide structures and their modes of action.

Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor.

Membrane disrupting lytic peptides for cancer treatments.

Host defense peptides as new weapons in cancer treatment.

P2888

s11274-017-2337-z

P304

177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11274-017-2337-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28921048

http://www.w3.org/2001/XMLSchema#string